Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voxelotor Effect on Exercise Capacity in Sickle Cell Anemia
NCT04581356Phase 4Completed
- Sponsor
- Elizabeth Yang
- Start
- Sep 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of voxelotor in sickle cell anemia (SCA), sponsored by Elizabeth Yang. Started Sep 2020; status: completed.
02
Drugs
voxelotor
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT04581356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581356.